Sandri A, Boschi F
Int J Mol Sci. 2025; 26(5).
PMID: 40076497
PMC: 11899166.
DOI: 10.3390/ijms26051871.
Hannawayya R, Puentes R, Mirzadzare N, Cirone K, Amin H, Soraisham A
Pediatr Res. 2025; .
PMID: 39856229
DOI: 10.1038/s41390-025-03882-9.
Chalmers J, Mall M, Chotirmall S, ODonnell A, Flume P, Hasegawa N
Eur Respir J. 2024; 65(1).
PMID: 39467608
PMC: 11694565.
DOI: 10.1183/13993003.01050-2024.
Hampton T, Barnaby R, Roche C, Nymon A, Fukutani K, MacKenzie T
Am J Physiol Lung Cell Mol Physiol. 2024; 327(6):L905-L916.
PMID: 39437760
PMC: 11684945.
DOI: 10.1152/ajplung.00272.2024.
Ciszek-Lenda M, Nowak B, Majka G, Suski M, Walczewska M, Fedor A
Inflamm Res. 2024; 73(8):1283-1297.
PMID: 38850343
PMC: 11282130.
DOI: 10.1007/s00011-024-01898-1.
TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases.
Almuntashiri S, Alhumaid A, Zhu Y, Han Y, Dutta S, Khilji O
Chin Med J Pulm Crit Care Med. 2024; 1(2):67-76.
PMID: 38343891
PMC: 10857872.
DOI: 10.1016/j.pccm.2023.05.002.
Advancements in preclinical human-relevant modeling of pulmonary vasculature on-chip.
Vo Q, Benam K
Eur J Pharm Sci. 2024; 195:106709.
PMID: 38246431
PMC: 10939731.
DOI: 10.1016/j.ejps.2024.106709.
Extracellular vesicles secreted by primary human bronchial epithelial cells reduce burden and inflammation in cystic fibrosis mouse lung.
Sarkar S, Barnaby R, Nymon A, Taatjes D, Kelley T, Stanton B
Am J Physiol Lung Cell Mol Physiol. 2023; 326(2):L164-L174.
PMID: 38084406
PMC: 11279747.
DOI: 10.1152/ajplung.00253.2023.
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.
Tedbury P, Manfredi C, Degenhardt F, Conway J, Horwath M, McCracken C
FASEB J. 2023; 37(11):e23220.
PMID: 37801035
PMC: 10760435.
DOI: 10.1096/fj.202300077R.
Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators.
Capraro M, Pedrazzi M, De Tullio R, Manfredi M, Cresta F, Castellani C
Int J Mol Sci. 2023; 24(17).
PMID: 37686190
PMC: 10488059.
DOI: 10.3390/ijms241713384.
Easy-to-Build and Reusable Microfluidic Device for the Dynamic Culture of Human Bronchial Cystic Fibrosis Epithelia.
Mazio C, Scognamiglio L, Passariello R, Panzetta V, Casale C, Urciuolo F
ACS Biomater Sci Eng. 2023; 9(5):2780-2792.
PMID: 37019688
PMC: 10170479.
DOI: 10.1021/acsbiomaterials.2c01460.
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond.
Mall M, Criner G, Miravitlles M, Rowe S, Vogelmeier C, Rowlands D
Eur Respir J. 2023; 61(4).
PMID: 37003609
PMC: 10066568.
DOI: 10.1183/13993003.01307-2022.
Neutrophil Extracellular Traps in Airway Diseases: Pathological Roles and Therapeutic Implications.
Jo A, Kim D
Int J Mol Sci. 2023; 24(5).
PMID: 36902466
PMC: 10003347.
DOI: 10.3390/ijms24055034.
The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients?.
Esposito R, Mirra D, Spaziano G, Panico F, Gallelli L, dAgostino B
Biomolecules. 2023; 13(2).
PMID: 36830719
PMC: 9952876.
DOI: 10.3390/biom13020350.
Genetic Deletion of Does Not Reduce Airway Inflammation and Structural Lung Damage in Mice with Cystic Fibrosis-like Lung Disease.
Wagner C, Balazs A, Schatterny J, Zhou-Suckow Z, Duerr J, Schultz C
Int J Mol Sci. 2022; 23(21).
PMID: 36362203
PMC: 9657231.
DOI: 10.3390/ijms232113405.
Mucosal Immunity in Cystic Fibrosis.
Bojanowski C, Lu S, Kolls J
J Immunol. 2022; 207(12):2901-2912.
PMID: 35802761
PMC: 9270582.
DOI: 10.4049/jimmunol.2100424.
Pathophysiology of Lung Disease and Wound Repair in Cystic Fibrosis.
Conese M, Di Gioia S
Pathophysiology. 2022; 28(1):155-188.
PMID: 35366275
PMC: 8830450.
DOI: 10.3390/pathophysiology28010011.
Sub-Antimicrobial Dosage Scheme of Doxycycline for the Chronic Treatment of Bronchiectasis in a Dog.
Szatmari V, van Geijlswijk I
Vet Sci. 2022; 9(3).
PMID: 35324864
PMC: 8954054.
DOI: 10.3390/vetsci9030137.
The Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease.
Mannion J, McLoughlin R, Lalor S
Clin Rev Allergy Immunol. 2022; 64(2):161-178.
PMID: 35275333
PMC: 10017631.
DOI: 10.1007/s12016-022-08928-y.
Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β are linked to inflammatory response in sputum of cystic fibrosis patients with .
Thomassen J, Trojan T, Walz M, Vohlen C, Fink G, Rietschel E
ERJ Open Res. 2021; 7(3).
PMID: 34291109
PMC: 8287132.
DOI: 10.1183/23120541.00636-2020.